z‐VAD‐FMK triggers macrophage necroptosis during mycobacterial infection via a non‐canonical off‐target mechanism
mLife · 2026-10 · 5 (5) · 637-650
DOI: 10.1002/mlf2.70101 ↗Kurz gefasst
Fachartikel in der Zeitschrift mLife, online erschienen am 01.10.2026. Verfasst von Rong Hu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Life Sciences Southern University of Science and Technology Shenzhen China. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NCI NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Macrophages are the predominant cell type infected by Mycobacterium tuberculosis (Mtb) in tuberculosis (TB). Death of Mtb‐infected macrophages promotes tissue pathology and releases Mtb to infect other cells, suggesting that inhibiting the death of Mtb‐infected macrophages could be an adjunctive treatment of TB. Prospects for such an intervention depend on identifying the molecular pathways leading to cell death. We previously reported that the death of Mtb‐infected mouse macrophages in vitro depends on type I interferons (IFNs) and lysosomal membrane permeabilization contributes to cell death. Here, we report that the death of Mtb‐infected primary mouse macrophages in vitro became necroptotic in the presence of a pan‐caspase inhibitor, benzyloxycarbonyl‐Val‐Ala‐Asp‐fluoromethylketone (z‐VAD‐FMK, hereafter called z‐VAD) acting on a target other than caspase‐8. Macrophages infected with Mycobacterium kansasii or Rhodococcus equi likewise underwent z‐VAD‐dependent necroptosis. In TB‐resistant C57BL/6 mice, the deficiency of the key necroptosis executioner, mixed lineage kinase domain‐like (MLKL), did not affect bacterial burden or pulmonary pathology. In contrast, in mice lacking the IFN repressor SP140, which express high levels of type I IFNs after Mtb infection and develop necrotic pulmonary lesions, MLKL‐deficiency reduced bacterial burden and pathology after high‐dose infection. This report illustrates that off‐target action(s) of a caspase‐8 inhibitor can switch the cell death pathway to necroptosis in macrophages infected with several Gram‐positive pathogens and highlights that necroptosis can exacerbate TB. Identifying the target of z‐VAD may help to delineate how necrotic lesions form in TB.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, School of Life Sciences Southern University of Science and Technology Shenzhen China.
- Shenzhen Third People's Hospital The Second Affiliated Hospital of Southern University of Science and Technology Shenzhen China.
- Department of Microbiology and Immunology Weill Cornell Medicine New York New York USA.
- Department of Immunology University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA.
- Tumor Microenvironment Center, UPMC Hillman Cancer Center University of Pittsburgh Pittsburgh Pennsylvania USA.
- Cancer Immunology and Immunotherapy Program UPMC Hillman Cancer Center Pittsburgh Pennsylvania USA.
ORCID-Profile: Li Zhang
Förderung
- NIGMS NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- Hearst Foundations
- National Institutes of Health
- National Natural Science Foundation of China
Zitieren
APA
Hu, R., Li, P., Han, J., Huang, J., Huang, G., Jiang, X., Pfau, D., Li, G., Gong, Y. N., Nathan, C. F., & Zhang, L. (2026). z‐VAD‐FMK triggers macrophage necroptosis during mycobacterial infection via a non‐canonical off‐target mechanism. mLife, 5(5), 637-650. https://doi.org/10.1002/mlf2.70101
Vancouver
Hu R, Li P, Han J, Huang J, Huang G, Jiang X, et al. z‐VAD‐FMK triggers macrophage necroptosis during mycobacterial infection via a non‐canonical off‐target mechanism. mLife. 2026;5(5):637-650. doi:10.1002/mlf2.70101
BibTeX
@article{Hu2026,
author = {Hu, Rong and Li, Pei and Han, Jie and Huang, Jiamin and Huang, Guoyi and Jiang, Xiuju and Pfau, Daniel and Li, Guobao and Gong, Yi-Nan and Nathan, Carl F and Zhang, Li},
title = {z‐VAD‐FMK triggers macrophage necroptosis during mycobacterial infection via a non‐canonical off‐target mechanism},
journal = {mLife},
year = {2026},
volume = {5},
number = {5},
pages = {637--650},
doi = {10.1002/mlf2.70101}
}
EUVIMED